SCHEDULE: RTW Investments Reports 5.7% Stake in uniQure N.V.

RTW Investments, LP and Roderick Wong, M.D. have filed a Schedule 13G, disclosing beneficial ownership of 5.7% of uniQure N.V.'s ordinary shares as of June 30, 2026.

Summary

• RTW Investments, LP and Roderick Wong, M.D. have jointly filed a Schedule 13G, indicating their beneficial ownership of uniQure N.V. ordinary shares.
• As of June 30, 2026, the reporting persons collectively beneficially owned 3,941,572 ordinary shares, representing 5.7% of the class.
• This filing is an update to reflect changes in beneficial ownership and is not an admission of beneficial ownership for purposes of Section 13 of the Securities Exchange Act of 1934.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative update regarding beneficial ownership rather than a strategic or financial performance announcement.

Positives

• RTW Investments, LP and Roderick Wong, M.D. are established entities in the investment space.
• The filing confirms a significant, though not controlling, stake (5.7%) in uniQure N.V., suggesting a level of confidence or strategic interest.

Negatives

• The filing does not provide any financial performance data or strategic updates for uniQure N.V., limiting insight into the company's operational health.
• The nature of the filing as a Schedule 13G indicates it's an ownership disclosure, not a performance report, thus offering no direct positive or negative operational news.

Risks

• The filing does not explicitly mention any risks associated with uniQure N.V.'s operations or the investment itself.
• Potential future changes in beneficial ownership by RTW Investments, LP or other large shareholders could impact uniQure N.V.'s stock price.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding uniQure N.V.'s future performance.

Management Comments

• The filing should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, as amended, the beneficial owner of the Shares reported herein.
• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. This filing indicates RTW Investments, LP's interest in uniQure N.V., a company operating in the gene therapy sector, which is characterized by high R&D investment and potential for significant therapeutic breakthroughs.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by RTW Investments, LP may influence market perception and trading activity.
• uniQure N.V. Management: The increased visibility of a substantial institutional investor may lead to engagement on strategic matters.

Next Steps

• RTW Investments, LP and Roderick Wong, M.D. will file additional amendments to the Schedule 13G as necessary.
• Continued monitoring of uniQure N.V.'s operational and financial performance will be necessary to assess the investment's trajectory.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, RTW Investments, uniQure N.V., Ordinary Shares, Investment Adviser, Roderick Wong